9 Meters Biopharma, Inc.

NasdaqCM:NMTR Stock Report

Mkt Cap: US$25.8m

9 Meters Biopharma Management

How experienced are the management team and are they aligned to shareholders interests?

1.0yrs

Average management tenure


CEO

John Temperato (57 yo)

2.75yrs

Tenure

US$2,187,794

Compensation

Mr. John Temperato has been President, Chief Executive Officer and Director at 9 Meters Biopharma Inc. (formerly known as 9 Meters Biopharma, Inc.) since April 30, 2020. Mr. Temperato served as Chief Execu...


CEO Compensation Analysis

How has John Temperato's remuneration changed compared to 9 Meters Biopharma's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$41m

Jun 30 2022n/an/a

-US$46m

Mar 31 2022n/an/a

-US$43m

Dec 31 2021US$2mUS$537k

-US$37m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$27m

Mar 31 2021n/an/a

-US$63m

Dec 31 2020US$2mUS$329k

-US$61m

Compensation vs Market: John's total compensation ($USD2.19M) is above average for companies of similar size in the US market ($USD724.75K).

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
John Temperato
President2.75yrsUS$2.19m0.55%
$ 142.0k
Bethany Sensenig
Chief Financial Officer1yrno datano data
Sireesh Appajosyula
Senior VP of Corporate Development & Operationsno datano datano data
Albert Medwar
Senior Vice President of Investor Relations & Corporate Communications1yrno datano data
Jerry Gardner
Head of Clinical Strategyno datano datano data
Patrick Griffin
Chief Medical Officer3.92yrsUS$950.08kno data
Nir Barak
Senior Vice President of Scientific Affairsno datano datano data
Sarah Liu
Chief Commercial Officer1yrno datano data
Peter H. Green
Clinical & Scientific Advisor and Consultantno datano datano data
Joseph Murray
Clinical & Scientific Advisor and Consultantno datano datano data
Ciaran Kelly
Clinical & Scientific Advisor and Consultantno datano datano data
Elena Verdu
Clinical & Scientific Advisor and Consultantno datano datano data

1.0yrs

Average Tenure

57yo

Average Age

Experienced Management: NMTR's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
John Temperato
President2.75yrsUS$2.19m0.55%
$ 142.0k
Lorin Johnson
Independent Director5yrsUS$134.39k0.033%
$ 8.4k
Mark Sirgo
Independent Chairman2.75yrsUS$169.39k0.61%
$ 157.4k
Mark Pimentel
Member of Scientific Advisory Board2.42yrsno datano data
Michael Rice
Independent Director1.92yrsUS$188.35k0%
$ 0
Michael Constantino
Independent Director2.58yrsUS$133.14k0.023%
$ 6.0k
Z. Falchuk
Member of Scientific Advisory Board2.42yrsno datano data
Maureen Leonard
Member of Scientific Advisory Board2.42yrsno datano data
Russel Cohen
Member of Scientific Advisory Board2.42yrsno datano data
Benjamin Lebwohl
Member of Scientific Advisory Board2.42yrsno datano data
Charles Randall
Member of Scientific Advisory Board2.42yrsno datano data
Samantha Ventimiglia
Independent Director1.25yrsUS$121.04k0%
$ 0

2.4yrs

Average Tenure

58yo

Average Age

Experienced Board: NMTR's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.